ask="10.90"
ask_size="500"
average_daily_volume="2121870"
bid="10.75"
bid_size="200"
book_value="-0.09"
change="-0.50"
change_from_200_day_moving_average="0.19"
change_from_50_day_moving_average="-0.47"
change_from_52_week_high="-3.49"
change_From_52_week_low="3.93"
change_in_percent="-4.39%"
close="10.89"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.56"
ebitda="-52.95M"
eps_estimate_current_year="-0.87"
eps_estimate_next_quarter="-0.23"
eps_estimate_next_year="-0.74"
ex_dividend_date="N/A"
float_shares="94923000"
high="11.30"
high_52_weeks="14.38"
last_trade_date="1/17/2017"
last_trade_price="10.89"
last_trade_size="95631"
last_trade_time="4:00pm"
low="10.78"
low_52_weeks="6.96"
market_capitalization="1.40B"
moving_average_200_day="10.70"
moving_average_50_day="11.36"
name="Halozyme Therapeutics
Inc."
notes="N/A"
one_year_target_price="14.84"
open="11.22"
pe_ratio="N/A"
peg_ratio="-0.28"
percent_change_from_200_day_moving_average="+1.81%"
percent_change_from_50_day_moving_average="-4.14%"
percent_change_from_52_week_high="-24.27%"
percent_change_from_52_week_low="+56.47%"
previous_close="11.39"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="9.13"
revenue="159.91M"
shares_outstanding="128154000"
short_ratio="18.81"
stock_exchange="NMS"
symbol="HALO"
volume="1842567"
weeks_range_52="6.96 - 14.38"
